Dr. Sarunya Yuthagovit, a top neurosurgeon specializing in neurovascular surgery, provides rare expert oversight for this protocol. The evidence-based treatment administers a precise dose of 2 million cells per kilogram across three phases over six months. At EDNA Wellness, the approximately $9,850 package includes the full treatment protocol and safety monitoring, developed within the clinic's established neurological training programs.
トンタイシン医師はベガクリニックにて再生医療を専門とし、米国再生医療学会（American Board of Regenerative Medicine）の認定を取得しています。
タイで初めて下垂体腫瘍に対する低侵襲脳外科手術を先導したポルポン医師は、EDNA ウェルネスにて幹細胞治療に脳神経外科の高い精度をもたらしています。
Dr. Siriporn Cheawchanwej is an aesthetic physician at Somchai Clinic in Bangkok. She has performed over 15,000 procedures throughout her career. She holds a Diploma in Aesthetic Medicine from the American Academy of Aesthetic Medicine. Dr. Cheawchanwej completed specific training in facial design at Mae Fah Luang University.
Dr. Kanokkaew Viravan is a US-trained pediatrician at Intrarat Hospital in Bangkok. She is a Diplomate of the American Board of Pediatrics. Dr. Viravan earned her medical degree from the Medical University of South Carolina, USA. She specializes in general pediatric care, including vaccinations and developmental conditions.
Stem cell therapy is not a proven cure for autism in Thailand or anywhere else. Thai clinics offer protocols using mesenchymal stem cells (MSCs). However, bodies like the International Society for Stem Cell Research (ISSCR) classify these as experimental.
Bookimed Expert Insight: Thai clinics like Vega Clinic and EDNA Wellness create structured programs. These often bundle 3–4 days in hospital with 20 to 70 million MSCs. These high-dose protocols are popular. However, families should note the A$28,300 Australian average for similar experimental care. Saving up to 69% in Thailand includes transfers and clinical oversight. Still, the medicine remains experimental.
Patient Consensus: Families in Thailand often report temporary improvements in alertness or calmness. These stories are anecdotal. They do not prove a permanent cure for autism.
Potential medical risks for autism stem cell therapy in Thailand include systemic immune reactions and gastrointestinal distress. Patients may also experience neurological changes like temporary irritability. Severe risks include tumours, infections from poor lab standards, and immune rejection when using donor cells.
Bookimed Expert Insight: Many clinics offer stem cell therapy. Australian patients should look for GMP-certified facilities. For example, Panacee Hospital Rama 2 and The Demarest Clinic use AABB-certified processes for cell preservation. These certifications provide a verifiable standard for cell purity and laboratory safety.
Patient Consensus: Families in Thailand recommend asking for specific sterile testing results to avoid infection risks. Most emphasise that while physical pain is short-term, observing long-term safety requires independent evidence.
Autism treatments in Thailand primarily use allogeneic mesenchymal stem cells (MSCs). These usually come from umbilical cord tissue known as Wharton’s jelly. Clinics also offer autologous bone marrow cells and cord blood mononuclear cells. These aim to reduce inflammation and improve blood flow to the brain.
Bookimed Expert Insight: Leading centres like Vega Clinic and EDNA Wellness offer hybrid protocols. These combine IV and IT administration. While IV targets inflammation, IT injections aim to bypass the blood-brain barrier. Patients often choose the 70 million MSC dose for intensive support.
Patient Consensus: Families recommend checking if the clinic uses expanded MSCs or cord blood. Transparent clinics provide specific cell counts and GMP manufacturing certificates for peace of mind.
Thailand clinics typically accept patients from early childhood through young adulthood. This range makes the most of higher neuroplasticity. Absolute contraindications include active infections, blood disorders, tumours, or unstable organ failure. Eligibility is confirmed through a specialist review of medical history and lab results.
Bookimed Expert Insight: Many centres accept international patients. Clinics like Panacee Hospital Rama 2 prioritise safety by using GMP-certified labs. This certification is a vital quality marker for Australians. It confirms the injected stem cells meet strict international purity and potency standards.
Patient Consensus: Families in Thailand find that clinics assess candidates individually. Most centres avoid using strict age cut-offs. Pre-treatment screening involves detailed medical questionnaires and prior records to confirm patient stability.
Thai treatment programmes use umbilical cord-derived mesenchymal stem cells to target neuroinflammation and repair neural pathways. Providers claim these cells secrete anti-inflammatory cytokines to calm immune responses. They also release growth factors like brain-derived neurotrophic factor to improve communication between brain regions. This may also enhance synaptic repair.
Bookimed Expert Insight: Thai clinics often recommend a specific 8-day protocol for international patients. This includes a 3-day hospital stay followed by local recovery. Vega Clinic highlights this timeframe for Australian families. It keeps the patient under clinical observation while neuroplasticity is supposedly highest.
Patient Consensus: Families travelling to Thailand frequently observe gradual improvements in eye contact and social responsiveness. These changes often appear within three months. Many note better sleep patterns and a reduction in sensory hypersensitivity following the programme.
Stem cell therapy for autism in Thailand is administered primarily through intravenous infusions and intrathecal injections. Facilities in Bangkok use donor-derived umbilical cord mesenchymal stem cells (MSCs). These protocols target inflammation and deliver cells directly to the cerebrospinal fluid to bypass the blood-brain barrier.
Bookimed Expert Insight: Thai clinics frequently offer graded dosage tiers that impact the administration timeline. For instance, a 20-million-cell IV protocol typically requires only 2 days in a hospital room. Higher-dose 70-million-cell combination treatments usually extend the stay to 4 days for monitoring.
Patient Consensus: Families travelling to Thailand report that treatment is a multi-day process. It involves blood tests and consultations rather than a same-day visit. Parents suggest confirming the cell source and requesting written laboratory certifications for cell processing before starting.